113 related articles for article (PubMed ID: 12620662)
1. Cytotoxic 2',5'-dihydroxychalcones with unexpected antiangiogenic activity.
Nam NH; Kim Y; You YJ; Hong DH; Kim HM; Ahn BZ
Eur J Med Chem; 2003 Feb; 38(2):179-87. PubMed ID: 12620662
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and cytotoxicity of 2,5-dihydroxychalcones and related compounds.
Nam NH; Hong DH; You YJ; Kim Y; Bang SC; Kim HM; Ahn BZ
Arch Pharm Res; 2004 Jun; 27(6):581-8. PubMed ID: 15283456
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic activity of Bupleurum longiradiatum on human umbilical venous endothelial cells.
You YJ; Lee IS; Kim Y; Bae KH; Ahn BZ
Arch Pharm Res; 2002 Oct; 25(5):640-2. PubMed ID: 12433197
[TBL] [Abstract][Full Text] [Related]
4. Deoxypodophyllotoxin; the cytotoxic and antiangiogenic component from Pulsatilla koreana.
Kim Y; Kim SB; You YJ; Ahn BZ
Planta Med; 2002 Mar; 68(3):271-4. PubMed ID: 11914969
[TBL] [Abstract][Full Text] [Related]
5. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
6. Synthetic chalcone derivatives as inhibitors of cathepsins K and B, and their cytotoxic evaluation.
Ramalho SD; Bernades A; Demetrius G; Noda-Perez C; Vieira PC; Dos Santos CY; da Silva JA; de Moraes MO; Mousinho KC
Chem Biodivers; 2013 Nov; 10(11):1999-2006. PubMed ID: 24243608
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic and antivascular 1-methyl-4-(3-fluoro-4-methoxyphenyl)-5-(halophenyl)-imidazoles.
Biersack B; Muthukumar Y; Schobert R; Sasse F
Bioorg Med Chem Lett; 2011 Nov; 21(21):6270-3. PubMed ID: 21963303
[TBL] [Abstract][Full Text] [Related]
8. Novel anthraquinone based chalcone analogues containing an imine fragment: synthesis, cytotoxicity and anti-angiogenic activity.
Kolundžija B; Marković V; Stanojković T; Joksović L; Matić I; Todorović N; Nikolić M; Joksović MD
Bioorg Med Chem Lett; 2014 Jan; 24(1):65-71. PubMed ID: 24332490
[TBL] [Abstract][Full Text] [Related]
9. Novel chalcone derivatives as hypoxia-inducible factor (HIF)-1 inhibitor: synthesis, anti-invasive and anti-angiogenic properties.
Wang L; Chen G; Lu X; Wang S; Han S; Li Y; Ping G; Jiang X; Li H; Yang J; Wu C
Eur J Med Chem; 2015 Jan; 89():88-97. PubMed ID: 25462229
[TBL] [Abstract][Full Text] [Related]
10. Luminescent Gold(I) Complexes of 1-Pyridyl-3-anthracenylchalcone Inducing Apoptosis in Colon Carcinoma Cells and Antivascular Effects.
González JJ; Ortega E; Rothemund M; Gold M; Vicente C; de Haro C; Bautista D; Schobert R; Ruiz J
Inorg Chem; 2019 Oct; 58(19):12954-12963. PubMed ID: 31550148
[TBL] [Abstract][Full Text] [Related]
11. Anti-angiogenic and anti-tumor activities of 2'-hydroxy-4'-methoxychalcone.
Lee YS; Lim SS; Shin KH; Kim YS; Ohuchi K; Jung SH
Biol Pharm Bull; 2006 May; 29(5):1028-31. PubMed ID: 16651739
[TBL] [Abstract][Full Text] [Related]
12. 3,4-Dihydroxychalcones as potent 5-lipoxygenase and cyclooxygenase inhibitors.
Sogawa S; Nihro Y; Ueda H; Izumi A; Miki T; Matsumoto H; Satoh T
J Med Chem; 1993 Nov; 36(24):3904-9. PubMed ID: 8254620
[TBL] [Abstract][Full Text] [Related]
13. Antivascular and antitumor properties of the tubulin-binding chalcone TUB091.
Canela MD; Noppen S; Bueno O; Prota AE; Bargsten K; Sáez-Calvo G; Jimeno ML; Benkheil M; Ribatti D; Velázquez S; Camarasa MJ; Díaz JF; Steinmetz MO; Priego EM; Pérez-Pérez MJ; Liekens S
Oncotarget; 2017 Feb; 8(9):14325-14342. PubMed ID: 27224920
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of N-(4-hydroxy-3-mercaptonaphthalen-1-yl)amides as inhibitors of angiogenesis and tumor growth.
Xu F; Jia Y; Wen Q; Wang X; Zhang L; Zhang Y; Yang K; Xu W
Eur J Med Chem; 2013 Jun; 64():377-88. PubMed ID: 23644219
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activities of fluorinated chalcone derivatives.
Nakamura C; Kawasaki N; Miyataka H; Jayachandran E; Kim IH; Kirk KL; Taguchi T; Takeuchi Y; Hori H; Satoh T
Bioorg Med Chem; 2002 Mar; 10(3):699-706. PubMed ID: 11814858
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Biological Evaluation of Indole-2-carbohydrazide Derivatives as Anticancer Agents with Anti-angiogenic and Antiproliferative Activities.
Zhang J; Liu T; Chen M; Liu F; Liu X; Zhang J; Lin J; Jin Y
ChemMedChem; 2018 Jun; 13(12):1181-1192. PubMed ID: 29637713
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel benzylidene-succinimide derivatives as noncytotoxic antiangiogenic inhibitors with anticolorectal cancer activity in vivo.
Luo K; Bao Y; Liu F; Xiao C; Li K; Zhang C; Huang R; Lin J; Zhang J; Jin Y
Eur J Med Chem; 2019 Oct; 179():805-827. PubMed ID: 31295714
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structure-activity relationships and biological evaluation of barbigerone analogues as anti-proliferative and anti-angiogenesis agents.
Wang G; Wang F; Cao D; Liu Y; Zhang R; Ye H; Li X; He L; Yang Z; Ma L; Peng A; Xiang M; Wei Y; Chen L
Bioorg Med Chem Lett; 2014 Jul; 24(14):3158-63. PubMed ID: 24863745
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues.
Nuti E; Bassani B; Camodeca C; Rosalia L; Cantelmo A; Gallo C; Baci D; Bruno A; Orlandini E; Nencetti S; Noonan DM; Albini A; Rossello A
Eur J Med Chem; 2017 Sep; 138():890-899. PubMed ID: 28750311
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anti-tumor activity of novel combretastatins: combretocyclopentenones and related analogues.
Nam NH; Kim Y; You YJ; Hong DH; Kim HM; Ahn BZ
Bioorg Med Chem Lett; 2002 Aug; 12(15):1955-8. PubMed ID: 12113817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
